A High-Protein Diet Promotes Atrial Arrhythmogenesis via Absent-in-Melanoma 2 Inflammasome

Jia Song1, Jiao Wu2, Dexter J Robichaux3

  • 1Department of Medicine, Section of Cardiovascular Research, Baylor College of Medicine, Houston, TX 77030, USA.

Cells
|January 22, 2024
PubMed

Insights

High-protein diets increase atrial fibrillation risk by activating the AIM2 inflammasome, leading to abnormal calcium release in heart cells. Targeting this pathway may offer new atrial fibrillation treatments.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Dietary Science

Background:

  • High-protein diets (HPDs) are linked to weight management and metabolic improvements.
  • The impact of HPDs on cardiac arrhythmogenesis, particularly atrial fibrillation (AF), is not well understood.
  • Inflammasome activation, specifically involving Absent-in-Melanoma 2 (AIM2), is implicated in AF but its role in HPD-induced AF is unexplored.

Purpose of the Study:

  • To investigate the effect of HPD on AF susceptibility.
  • To determine the role of AIM2 inflammasome signaling in HPD-induced AF.
  • To elucidate the mechanisms linking HPD, AIM2 activation, and AF.

Main Methods:

  • Wildtype and Aim2-deficient mice were fed either normal chow or HPD for four weeks.
  • Inflammasome activity, cytoplasmic DNA levels, mitochondrial reactive oxygen species (ROS), and sarcoplasmic reticulum (SR) Ca2+ release were assessed.
  • AF susceptibility was evaluated in the different mouse groups.

Main Results:

  • HPD significantly increased susceptibility to AF in wildtype mice.
  • Inflammasome activity and cytoplasmic double-strand DNA levels were elevated in the atria of HPD-fed wildtype mice.
  • Genetic inhibition of AIM2 in Aim2-deficient mice attenuated HPD-induced AF, reduced cytoplasmic dsDNA, mitochondrial ROS, and normalized SR Ca2+ release.

Conclusions:

  • HPD promotes AF development by activating the AIM2 inflammasome pathway.
  • AIM2 activation by HPD is associated with mitochondrial oxidative stress and proarrhythmic SR Ca2+ release.
  • Targeting the AIM2 inflammasome may represent a novel therapeutic strategy for AF in specific patient populations.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
1.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.6K